Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.61 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.61 |
| ▸ | FABP3 | P05413 | 6/20 | 0.62 |
| ▸ | TERT | O14746 | 3/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.61 |
| ▸ | PPARG | P37231 | 3/20 | 0.61 |
| ▸ | PPARD | Q03181 | 3/20 | 0.61 |
| ▸ | PPARA | Q07869 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | BLM | P54132 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | FABP4 | P15090 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | F7 | P08709 | 2/20 | 0.61 |
| ▸ | F3 | P13726 | 2/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL35815 | 1.00 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Hydrochloric Acid SCHEMBL826065 | 1.00 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| SCHEMBL7045888 | 0.98 | FABP3 (0.65) | FABP3TERTPTPN1PPARGPPARD | |
| SCHEMBL4133929 | 0.98 | FABP3 (0.65) | FABP3TERTPTPN1PPARGPPARD | |
| SCHEMBL1626315 | 0.98 | FABP3 (0.65) | FABP3TERTPTPN1PPARGPPARD | |
| Water SCHEMBL3915284 | 0.96 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Water SCHEMBL3915280 | 0.96 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Propane SCHEMBL480215 | 0.96 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Bromide SCHEMBL3414482 | 0.96 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Iodide SCHEMBL6695071 | 0.96 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6700 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139254-A1 | INTERFERING RNA FOR INHIBITING TOP1 GENE EXPRESSION AND USE THEREOF | JENKEM TECH CO LTD BEIJING (CN) | 2026-05-21 | — | — | US | claimed |
| WO-2026101351-A1 | METHOD FOR PREPARING LIPID NANOPARTICLES | 주식회사 테르나테라퓨틱스 | 2026-05-15 | — | — | WO | claimed |
| EP-4734964-A1 | LIPID PARTICLES FOR DELIVERING A PAYLOAD | Repertoire Immune Medicines, Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| US-20260108473-A1 | BISPECIFIC STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | GENERATION BIO CO (US) | 2026-04-23 | — | — | US | claimed |
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-03-10 | — | — | US | claimed |
| US-20260062716-A1 | LIPID NANOPARTICLE (LNP) COMPOSITION OR FORMULATION FOR NUCLEIC ACID THERAPEUTICS | POPVAX PRIVATE LTD (IN) | 2026-03-05 | — | — | US | claimed |
| EP-4695401-A1 | SYNTHETIC CIRCUITS AND USES THEREOF | Strand Therapeutics Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4321504-B1 | PEGYLATED LIPID AND LIPOSOME MODIFIED THEREBY, AND PHARMACEUTICAL COMPOSITION COMPRISING LIPOSOME AND PREPARATION AND USE THEREOF | XIAMEN SINOPEG BIOTECH CO LTD (CN) | 2026-02-18 | — | — | EP | claimed |
| US-20260041643-A1 | STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | GENERATION BIO CO (US) | 2026-02-12 | — | — | US | claimed |
| US-20260041754-A1 | NANOPARTICLE COMPLEXES FOR ENHANCED SAFETY | HDT BIO CORP (US) | 2026-02-12 | — | — | US | claimed |
| US-5969011-A | AQUEOUS DISPERSION OF SIZING AGENT CONTAINING CELLULOSE-REACTIVE AGENT AND DISPERSANT SYSTEM COMPRISING LOW MOLECULAR WEIGHT CATIONIC ORGANIC COMPOUD AND ANIONIC POLYELECTROLYTE STABILIZER | AKZO NOBEL NV (NL) | 1999-10-19 | — | — | US | claimed |
| US-5885613-A | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 1999-03-23 | — | — | US | claimed |
| WO-1999005303-A1 | PREPARATION OF LIPID-NUCLEIC ACID PARTICLES USING A SOLVENT EXTRACTION AND DIRECT HYDRATION METHOD | INEX PHARMACEUTICALS CORPORATION (CA) | 1999-02-04 | — | — | WO | claimed |
| WO-1998033979-A1 | SIZING OF PAPER | AKZO NOBEL N.V. (NL) | 1998-08-06 | — | — | WO | claimed |
| US-5780009-A | MILK PRODUCTION | NEXIA BIOTECHNOLOGIES, INC. (CA) | 1998-07-14 | — | — | US | claimed |
| EP-0805869-A2 | DIRECT GENE TRANSFER INTO THE RUMINANT MAMMARY GLAND | Nexia Biotechnologies, Inc. (CA) | 1997-11-12 | — | — | EP | claimed |
| EP-0792142-A1 | BILAYER STABILIZING COMPONENTS AND THEIR USE IN FORMING PROGRAMMABLE FUSOGENIC LIPOSOMES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 1997-09-03 | — | — | EP | claimed |
| WO-1996022379-A2 | DIRECT GENE TRANSFER INTO THE RUMINANT MAMMARY GLAND | NEXIA BIOTECHNOLOGIES, INC. (CA) | 1996-07-25 | — | — | WO | claimed |
| WO-1996010392-A1 | BILAYER STABILIZING COMPONENTS AND THEIR USE IN FORMING PROGRAMMABLE FUSOGENIC LIPOSOMES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 1996-04-11 | — | — | WO | claimed |
| US-4294576-A | QUATERNARY AMMONIUM COMPOUND ADDITIVE | BASF AKTIENGESELLSCHAFT (DE) | 1981-10-13 | — | — | US | claimed |